EPIDEMIOLOGICAL AND MEDICAL BURDEN OF THE COVID-19

1

EPIDEMIOLOGICAL AND MEDICAL BURDEN OF THE COVID-19 PANDEMIC IN PEDIATRIC TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY ACROSS THE ERN-TRANSPLANTCHILD MEMBERS

Fields marked with * are mandatory.

EPIDEMIOLOGICAL AND MEDICAL BURDEN OF

THE COVID-19 PANDEMIC IN PEDIATRIC TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY ACROSS THE ERN-

TRANSPLANTCHILD MEMBERS

2

D e a r c o l l e a g u e s ,

After the successful first clinical audit about COVID-19 in pediatric transplanted patients across ERN-TransplantChild members, Padova team suggested to share the data about follow up and burden of the COVID-19 pandemic in pediatric transplant recipients among TransplantChild centres. We see this survey as the continuation of the first one and an opportunity to update the experience and knowledge on the effects of the SARS-CoV-2 i n f e c t i o n i n o u r p a t i e n t s .

Please with the results of the first clinical audit.find below the file

This audit, on "Epidemiological and medical burden of the COVID-19 pandemic in is a survey about your centre approach and resources pediatric transplant recipients"

related to SARS-CoV-2 infection and clinical case description and follow up of these patients.

A first draft of the survey was elaborated by Dr. M. Cananzi, Dr. E. Benetti, Dr. F. de Corti, Dr. D. Donà and Dr. G. Perilongo from Azienda Ospedalera di Padova and after suggestions of other members, modifications were incorporated resulting in the final survey format that we are now sending to all of you.

It would be great to have your responses throughout this month of , so that we can Aprilanalyze the results and prepare the first document with them in May.

As always, here at La Paz University Hospital we will be completely willing to collaborate in everything you need.

Thanks in advance for your collaboration, and we are looking forward to hearing from you.

Find below the article we published on the previous COVID-19 survey.2020_Pediatric_transplantation_in_Europe_during_the_COVID-

19_pandemic_Early_impact_on_activity_and_healthcare.pdf

Your name

Email

CentreVilnius University Hospital Santaros Klinikos, LithuaniaCentro Hospitalar e Universitário de Coimbra, Portugal

*

*

*

3

University Medical Center Utrecht, The NetherlandsChildren's Memorial Health Institute, PolandHospital Universitario la Paz, EspañaMedizinische Hochschule Hannover, GermanyCentro Hospitalar de Lisboa Norte, PortugalOspedale Papa Giovanni XXIII, Bergamo, ItalyCentro Hospitalar do Porto, PortugalKarolinska University Hospital, SwedenAssistance Publique Hôpitaux de Paris, Hôpital Bicêtre, FranceAssistance Publique Hôpitaux de Paris, Hôpital Necker Enfants Malades, FranceSkåne University Hospital, Lund, SwedenOspedale Pediatrico Bambino Gesù, Rome, ItalyUniversity Hospitals Saint Luc, BelgiumAzienda Ospedale Università Padova, ItalyISMETT Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, ItalyCentre for Pediatric Lung Transplantation, Medical University of Vienna, AustriaUniversity Hospital Centre Zagreb, CroatiaSemmelweis University, HungaryTartu University Hospital, EstoniaChildren’s Clinical University Hospital, Riga, LatviaCentre Hospitalier du Luxembourg, LuxembourgMater Dei Hospital, MaltaRigshospitalet University Hospital, DenmarkOdense University Hospital, DenmarkOther

Please, specify other centre name:

CENTRE-SPECIFIC QUESTIONS

Transplantation program:HeartHematopoietic stem cellIntestine/MultivisceralKidneyLiverLungPancreas

Characteristics of your Transplant Unit:MedicalSurgicalBoth

*

*

*

4

%

patients

Type of patients:Exclusively pediatricMixed pediatric-adult

How many children with SOT/HSCT do you follow?<5051-100101-149150-199>200

WHO COVID-19 def ini t ion of conf i rmed case*

*Please answer according to the WHO COVID-19 definition of the confirmed case as either:A. a child with a positive Nucleic Acid Amplification Test (NAAT); B. a child with a positive SARS-CoV-2 antigen-rapid diagnostic test (RDT) who meets clinical criteria and is a contact of a probable or confirmed case or is linked to a COVID-19 cluster;or C. an asymptomatic child with a positive SARS-CoV-2 antigen-RDT who is a contact of a probable or c o n f i r m e d c a s e .

*See attached WHO confirmed case definition for more details, if needed. WHO-2019-nCoV-Surveillance_Case_Definition-2020.2-eng.pdf

How many of your transplanted patients have been infected by since the beginning of the SARS-CoV-2*pandemic?

Only values between 0 and 100 are allowed

Percentage of your total patients:Only values between 0 and 100 are allowed

In your centre, have you specific test to assess the specific immune response to SARS-CoV-2?IgG anti-SARS-CoV-2 titrationB lymphocyte specific responseT lymphocyte specific responseCytokines productionOtherNone

Please, specify B lymphocyte specific response technique or method:

*

*

*

*

*

*

5

months

Please, specify T lymphocyte specific response technique or method:

Please, specify cytokines production technique or method:

Please, specify other technique or methods used:

Please, fill in the specific questions for each patient with COVID-19 you have. Once you have finished, go to the Submit section to finish the survey.

1. PATIENT-SPECIFIC QUESTIONS

* Age of the patient at the time of SARS-CoV-2 infection:

* Sex:FemaleMale

Country of residence (EU member states):- Austria- Belgium- Bulgaria- Croatia- Cyprus- Czechia- Denmark- Estonia- Finland- France- Germany- Greece- Hungary- Ireland- Italy

*

*

*

6

- Latvia- Lithuania- Luxembourg- Malta- Netherlands- Poland- Portugal- Romania- Slovak Republic- Slovenia- Spain- Sweden

Country of residence (Non- EU member sate):- Afghanistan- Albania- Algeria- Andorra- Angola- Antigua and Barbuda- Argentina- Armenia- Australia- Austria- Azerbaijan- Bahamas- Bahrain- Bangladesh- Barbados- Belarus- Belgium- Belize- Benin- Bhutan- Bolivia- Bosnia and Herzegovina- Botswana- Brazil- Brunei Darussalam- Bulgaria- Burkina Faso- Burundi- Cabo Verde- Cambodia- Cameroon- Canada- Central African Republic

7

- Chad- Chile- China- Colombia- Comoros- Congo- Costa Rica- Côte D'Ivoire- Croatia- Cuba- Cyprus- Czechia- Democratic Republic of the Congo- Denmark- Djibouti- Dominica- Dominican Republic- Ecuador- Egypt- El Salvador- Equatorial Guinea- Eritrea- Estonia- Eswatini- Ethiopia- Fiji- Finland- France- Gabon- Gambia- Georgia- Germany- Ghana- Greece- Grenada- Guatemala- Guinea- Guinea Bissau- Guyana- Haiti- Honduras- Hungary- Iceland- India- Indonesia- Iran- Iraq

8

- Ireland- Israel- Italy- Jamaica- Japan- Jordan- Kazakhstan- Kenya- Kiribati- Kuwait- Kyrgyzstan- Laos- Latvia- Lebanon- Lesotho- Liberia- Libya- Liechtenstein- Lithuania- Luxembourg- Madagascar- Malawi- Malaysia- Maldives- Mali- Malta- Marshall Islands- Mauritania- Mauritius- Mexico- Micronesia- Monaco- Mongolia- Montenegro- Morocco- Mozambique- Myanmar- Namibia- Nauru- Nepal- Netherlands- New Zealand- Nicaragua- Niger- Nigeria- North Korea- North Macedonia

9

- Norway- Oman- Pakistan- Palau- Panama- Papua New Guinea- Paraguay- Peru- Philippines- Poland- Portugal- Qatar- Republic of Moldova- Romania- Russian Federation- Rwanda- Saint Kitts and Nevis- Saint Lucia- Saint Vincent and the Grenadines- Samoa- San Marino- Sao Tome and Principe- Saudi Arabia- Senegal- Serbia- Seychelles- Sierra Leone- Singapore- Slovakia- Slovenia- Solomon Islands- Somalia- South Africa- South Korea- South Sudan- Spain- Sri Lanka- Sudan- Suriname- Sweden- Switzerland- Syrian Arab Republic- Tajikistan- Tanzania- Thailand- Timor-Leste- Togo

10

- Tonga- Trinidad and Tobago- Tunisia- Turkey- Turkmenistan- Tuvalu- Uganda- Ukraine- United Arab Emirates- United Kingdom- United States of America- Uruguay- Uzbekistan- Vanuatu- Venezuela- Viet Nam- Yemen- Zambia- Zimbabwe

* City of residence:

* Type of transplantation:Hematopoietic stem cellHeartIntestine/MultivisceralKidneyLiverLungPancreasCombined

* Please, select type of transplantations received:between 2 and 7 choices

HeartHematopoietic stem cellIntestine/MultivisceralKidneyLiverLungPancreas

* Primary diagnosis (i.e., disease that led to transplantation):

11

months* Age of the patient at transplantation procedure (if more than one transplant, please write the last one):

Details of patient with confirmed SARS-CoV-2 infection according to the WHO definition

a. Health status of the patient at the time of SARS-CoV-2 infection

* Post-transplant health status at the time of SARS-CoV-2 infection:1-Poor2-Fair3-Average4-Good

* Co-morbidities at the time of SARS-CoV-2 infection:NoneHypertensionCardiac disordersPulmonary disordersDiabetesObesityOther

Please, specify cardiac disorder:

Please, specify pulmonary disorder:

Please, specify other co-morbidities at the time of SARS-CoV-2 infection:

b. Immunological status of the patient at the latest follow up visit (<6 months) before SARS-CoV-2 infection

* Ongoing immunosuppression:TacrolimusCyclosporineMycophenolate mofetil/mycophenolic acid

12

Everolimus/SirolimusPrednisoneRituximabOtherNone

* Please, specify other immunosuppressive agent:

* Has the patient received any monoclonal antibody and when?Rituximab (anti-CD20)Alemtuzumab (anti-CD52)Basilixumab/daclizumab (anti-CD25)OtherNone

* Please, specify dates (dd/mm/yy) for each dose of Rituximab:

* Please, specify dates (dd/mm/yy) for each dose of Alemtuzumab:

* Please, specify dates (dd/mm/yy) for each dose of Basilixumab/daclizumab:

* Please, specify the monoclonal ab and dates (dd/mm/yy) for each dose:

* Ongoing immunological complications at the time of SARS-CoV-2 infection:NoneAcute rejectionChronic rejectionGraft-versus-host disease (GVHD)Other

* Please, specify other immunological complications:

* Ongoing infectious complications at the time of SARS-CoV-2 infection:

13

NoneBacterial infectionViral infectionFungal infectionOther

* Please, select agent of bacterial infection:Acinetobacter baumaniiAntimicrobial-resistant enterococciBurkholderia cepacia groupCampylobacter sppClostridium difficileEnterobacter sppEnterococcus sppEscherichia coliKlebsiella sppLegionella sppListeria monocytogenesMethicillin-resistant staphylococciMultidrug-resistant gram-negative bacilliMycobacterium tuberculosisMycoplasma sppNocardia sppNontuberculous mycobacteriaOther gram-negative bacteriaOther gram-positive bacteriaPseudomonas aeruginosaS. epidermidisSalmonella sppSerratia sppStaphylococcus aureusStenotrophomonas maltophiliaStreptococcus pneumoniaeOther

* Please, select agent of viral infection:AdenovirusBK polyomavirusCMVEBVHBVHCVHHV6HHV8HSVInfluenza

14

JC polyomavirusMetapneumovirusNorovirusParainfluenza virusParvovirus B19RhinovirusRotavirusRSVVZVOther

* Please, select agent of fungal infection:Aspergillus sppCandida sppCryptococcus neoformansEndemic mycosisMucormycosisPneumocystis jiroveciiOther

* If any other, please specify:

* Leukocytes:NormalLeukocytosisLeukopeniaUnknown or not evaluated

* Neutrophils:NormalNeutrophiliaNeutropenia < 1000/mmcNeutropenia < 500/mmcUnknown or not evaluated

* Lymphocytes:NormalLymphocytosisLymphopenia < 1000/mmcLymphopenia < 500/mmcUnknown or not evaluated

* Immunoglobulins:Normal

15

Reduced <3 percentile for ageUnknown or not evaluated

c. SARS-CoV-2 infection

* Date of diagnosis:

* Diagnostic test:Nucleic Acid Amplification Test (NAAT)Antigen-Rapid Diagnostic Test (RDT)Antigen-Rapid Diagnostic Test (RDT) confirmed by a positive Nucleic Acid Amplification Test (NAAT)Other

* Please, specify other diagnostic test:

* Source of infection:Households with a probable or confirmed COVID-19Close contact with a probable or confirmed COVID-19 case at schoolClose contact with a probable or confirmed COVID-19 case at the hospital (during admissions or follow-up visits)Close contact with a probable or confirmed COVID-19 case out of school and out of the hospital (other than households contacts)UnknownOther

* Please, specify other source of infection:

* Test employed to monitor the recovery from SARS-CoV-2 infection (i.e. test employed to assess SARS-CoV-2 negativization after diagnosis):

Nucleic Acid Amplification Test (NAAT)Antigen-Rapid Diagnostic Test (RDT)Viral cultureNo test, the patient was considered recovered after 21 days from the resolution of symptomsOther

* Please, specify other type of monitoring:

16

weeks

* Duration of the infection (i.e. duration of SARS-CoV-2 positivity from diagnosis) as determined by the diagnostic test(s) selected

< 1 week< 2 weeks< 3 weeks< 4 weeksUnknownOther

* Please, specify other duration of the infection:

d. Clinical manifestations of SARS-CoV-2 infection

* Symptoms:None/asymptomatic infectionFeverHeadacheFatigueSore throatRespiratory symptomsGastrointestinal symptomsMuscle or body achesLoss of taste or smellMultisystem inflammatory syndrome in children (MIS-C)Other

* Please, specify type of respiratory symptoms:

* Please, specify type of gastrointestinal symptoms:

* Please, specify other type of symptoms:

* Lung imaging:NoneChest X-raysChest CT scanOther

17

weeks

* Please, specify the X-rays result:

* Please, specify the CT scan result:

* Please, specify other lung imaging and results:

* Injury to the transplanted graft (clinical, biochemical or radiological evidence):YesNoNot tested

* Please, specify the type of injury to the transplanted graft:

* Duration of symptoms:Asymptomatic infection< 1 week< 2 weeks< 3 weeks< 4 weeksUnknownOther

* Please, specify other duration of symptoms:

* Outcome:Complete recoveryRecovery with sequelaeDeath

* Please, specify the sequelae:

Please, specify the Date of death:*

18

days

days

e. SARS-CoV-2 management

* Respiratory support for SARS-CoV-2 infection:NoneOxygenNon-invasive ventilationInvasive mechanical ventilationHigh-frequency oscillatory ventilation (HFOV)ECMO

* Please, specify total duration:

* Pharmacological treatment of SARS-CoV-2 infection:NoneReduction of immunosuppressionStop immunosuppressionSteroid treatmentRemdesivirAntiviral treatment (not including remdesivir)Antibiotic treatmentHeparinHydroxychloroquineConvalescent plasma therapyOther

* Please, specify which IS and duration:

* Please, specify the duration of the stop immunosupression:

* Please, specify dose (mg/kg/day) and duration (days) of remdesivir treatment:

19

Please, specify steroid, other antiviral, antibiotic and/or heparin treatment:Name of drug Duration (days) Administration route

1

2

3

4

20

months

* Please, specify dose (mg/kg/day) and duration (days) of hydroxychloroquine treatment:

* Please, specify dose and number of administrations:

* Please, specify other type of drugs:

* Management of SARS-CoV-2 infection:None (the patient did not receive any medical support or follow up)Home medical visitsTelematic follow-upHospital admissionPediatric Intensive Care Unit (PICU) admissionOther

* Please, specify the indication of hospital admission:

* Please, specify the indication of PICU admission:

* Please, specify other:

Please, if you have more patients to add, go to the next section. If you have finished, go to the Submit section to finish the survey.



* Sex:FemaleMale

21

Country of residence (EU member states):AT - AustriaBE - BelgiumBG - BulgariaHR - CroatiaCY - CyprusCZ - CzechiaDK - DenmarkEE - EstoniaFI - FinlandFR - FranceDE - GermanyEL - GreeceHU - HungaryIE - IrelandIT - ItalyLV - LatviaLT - LithuaniaLU - LuxembourgMT - MaltaNL - NetherlandsPL - PolandPT - PortugalRO - RomaniaSK - Slovak RepublicSI - SloveniaES - SpainSE - Sweden

Country of residence (Non- EU member sate):AF - AfghanistanAL - AlbaniaDZ - AlgeriaAD - AndorraAO - AngolaAG - Antigua and BarbudaAR - ArgentinaAM - ArmeniaAU - AustraliaAT - AustriaAZ - AzerbaijanBS - BahamasBH - BahrainBD - BangladeshBB - BarbadosBY - Belarus

22

BE - BelgiumBZ - BelizeBJ - BeninBT - BhutanBO - BoliviaBA - Bosnia and HerzegovinaBW - BotswanaBR - BrazilBN - Brunei DarussalamBG - BulgariaBF - Burkina FasoBI - BurundiCV - Cabo VerdeKH - CambodiaCM - CameroonCA - CanadaCF - Central African RepublicTD - ChadCL - ChileCN - ChinaCO - ColombiaKM - ComorosCG - CongoCR - Costa RicaCI - Côte D'IvoireHR - CroatiaCU - CubaCY - CyprusCZ - CzechiaCD - Democratic Republic of the CongoDK - DenmarkDJ - DjiboutiDM - DominicaDO - Dominican RepublicEC - EcuadorEG - EgyptSV - El SalvadorGQ - Equatorial GuineaER - EritreaEE - EstoniaSZ - EswatiniET - EthiopiaFJ - FijiFI - FinlandFR - FranceGA - GabonGM - Gambia

23

GE - GeorgiaDE - GermanyGH - GhanaGR - GreeceGD - GrenadaGT - GuatemalaGN - GuineaGW - Guinea BissauGY - GuyanaHT - HaitiHN - HondurasHU - HungaryIS - IcelandIN - IndiaID - IndonesiaIR - IranIQ - IraqIE - IrelandIL - IsraelIT - ItalyJM - JamaicaJP - JapanJO - JordanKZ - KazakhstanKE - KenyaKI - KiribatiKW - KuwaitKG - KyrgyzstanLA - LaosLV - LatviaLB - LebanonLS - LesothoLR - LiberiaLY - LibyaLI - LiechtensteinLT - LithuaniaLU - LuxembourgMG - MadagascarMW - MalawiMY - MalaysiaMV - MaldivesML - MaliMT - MaltaMH - Marshall IslandsMR - MauritaniaMU - MauritiusMX - Mexico

24

FM - MicronesiaMC - MonacoMN - MongoliaME - MontenegroMA - MoroccoMZ - MozambiqueMM - MyanmarNA - NamibiaNR - NauruNP - NepalNL - NetherlandsNZ - New ZealandNI - NicaraguaNE - NigerNG - NigeriaKP - North KoreaMK - North MacedoniaNO - NorwayOM - OmanPK - PakistanPW - PalauPA - PanamaPG - Papua New GuineaPY - ParaguayPE - PeruPH - PhilippinesPL - PolandPT - PortugalQA - QatarMD - Republic of MoldovaRO - RomaniaRU - Russian FederationRW - RwandaKN - Saint Kitts and NevisLC - Saint LuciaVC - Saint Vincent and the GrenadinesWS - SamoaSM - San MarinoST - Sao Tome and PrincipeSA - Saudi ArabiaSN - SenegalRS - SerbiaSC - SeychellesSL - Sierra LeoneSG - SingaporeSK - SlovakiaSI - Slovenia

25

SB - Solomon IslandsSO - SomaliaZA - South AfricaKR - South KoreaSS - South SudanES - SpainLK - Sri LankaSD - SudanSR - SurinameSE - SwedenCH - SwitzerlandSY - Syrian Arab RepublicTJ - TajikistanTZ - TanzaniaTH - ThailandTL - Timor-LesteTG - TogoTO - TongaTT - Trinidad and TobagoTN - TunisiaTR - TurkeyTM - TurkmenistanTV - TuvaluUG - UgandaUA - UkraineAE - United Arab EmiratesGB - United KingdomUS - United States of AmericaUY - UruguayUZ - UzbekistanVU - VanuatuVE - VenezuelaVN - Viet NamYE - YemenZM - ZambiaZW - Zimbabwe


* Type of transplantation:Hematopoietic stem cellHeartIntestine/MultivisceralKidney

26

months

LiverLungPancreasCombined




* Age of the patient at transplantation procedure (if more than one transplant, please write the last one):






27




* Ongoing immunosuppression:TacrolimusCyclosporineMycophenolate mofetil/mycophenolic acidEverolimus/SirolimusPrednisoneRituximabOtherNone






28




* Ongoing infectious complications at the time of SARS-CoV-2 infection:NoneBacterial infectionViral infectionFungal infectionOther

* Please, select agent of bacterial infection:Acinetobacter baumaniiAntimicrobial-resistant enterococciBurkholderia cepacia groupCampylobacter sppClostridium difficileEnterobacter sppEnterococcus sppEscherichia coliKlebsiella sppLegionella sppListeria monocytogenesMethicillin-resistant staphylococciMultidrug-resistant gram-negative bacilliMycobacterium tuberculosisMycoplasma sppNocardia sppNontuberculous mycobacteriaOther gram-negative bacteriaOther gram-positive bacteriaPseudomonas aeruginosaS. epidermidisSalmonella sppSerratia spp

29

Staphylococcus aureusStenotrophomonas maltophiliaStreptococcus pneumoniaeOther

* Please, select agent of viral infection:AdenovirusBK polyomavirusCMVEBVHBVHCVHHV6HHV8HSVInfluenzaJC polyomavirusMetapneumovirusNorovirusParainfluenza virusParvovirus B19RhinovirusRotavirusRSVVZVOther




30



* Immunoglobulins:NormalReduced <3 percentile for ageUnknown or not evaluated







31

weeks










32











33

days

weeks



Please, specify the Date of death:






*

34

days* Please, specify the duration of the stop immunosupression:


35


1

2

3

4

36

months











* Sex:FemaleMale

37

Country of residence (EU member states):[ID85] - Austria[ID86] - Belgium[ID87] - Bulgaria[ID88] - Croatia[ID89] - Cyprus[ID90] - Czechia[ID91] - Denmark[ID92] - Estonia[ID93] - Finland[ID94] - France[ID95] - Germany[ID96] - Greece[ID97] - Hungary[ID98] - Ireland[ID99] - Italy[ID100] - Latvia[ID101] - Lithuania[ID102] - Luxembourg[ID103] - Malta[ID104] - Netherlands[ID105] - Poland[ID106] - Portugal[ID107] - Romania[ID108] - Slovak Republic[ID109] - Slovenia[ID110] - Spain[ID111] - Sweden

Country of residence (Non- EU member sate):[ID113] - Afghanistan[ID114] - Albania[ID115] - Algeria[ID116] - Andorra[ID117] - Angola[ID118] - Antigua and Barbuda[ID119] - Argentina[ID120] - Armenia[ID121] - Australia[ID122] - Austria[ID123] - Azerbaijan[ID668] - Bahamas[ID669] - Bahrain[ID670] - Bangladesh[ID671] - Barbados[ID672] - Belarus

38

[ID673] - Belgium[ID689] - Belize[ID690] - Benin[ID691] - Bhutan[ID692] - Bolivia[ID693] - Bosnia and Herzegovina[ID694] - Botswana[ID695] - Brazil[ID696] - Brunei Darussalam[ID697] - Bulgaria[ID698] - Burkina Faso[ID699] - Burundi[ID700] - Cabo Verde[ID701] - Cambodia[ID702] - Cameroon[ID703] - Canada[ID704] - Central African Republic[ID705] - Chad[ID706] - Chile[ID707] - China[ID708] - Colombia[ID709] - Comoros[ID710] - Congo[ID711] - Costa Rica[ID716] - Côte D'Ivoire[ID712] - Croatia[ID713] - Cuba[ID714] - Cyprus[ID715] - Czechia[ID717] - Democratic Republic of the Congo[ID718] - Denmark[ID719] - Djibouti[ID720] - Dominica[ID721] - Dominican Republic[ID722] - Ecuador[ID723] - Egypt[ID724] - El Salvador[ID725] - Equatorial Guinea[ID726] - Eritrea[ID727] - Estonia[ID728] - Eswatini[ID729] - Ethiopia[ID730] - Fiji[ID731] - Finland[ID732] - France[ID733] - Gabon[ID734] - Gambia

39

[ID735] - Georgia[ID736] - Germany[ID737] - Ghana[ID738] - Greece[ID739] - Grenada[ID740] - Guatemala[ID741] - Guinea[ID742] - Guinea Bissau[ID743] - Guyana[ID744] - Haiti[ID745] - Honduras[ID746] - Hungary[ID747] - Iceland[ID748] - India[ID749] - Indonesia[ID750] - Iran[ID751] - Iraq[ID752] - Ireland[ID753] - Israel[ID754] - Italy[ID755] - Jamaica[ID756] - Japan[ID757] - Jordan[ID758] - Kazakhstan[ID759] - Kenya[ID760] - Kiribati[ID761] - Kuwait[ID762] - Kyrgyzstan[ID763] - Laos[ID764] - Latvia[ID765] - Lebanon[ID766] - Lesotho[ID767] - Liberia[ID768] - Libya[ID769] - Liechtenstein[ID770] - Lithuania[ID771] - Luxembourg[ID772] - Madagascar[ID773] - Malawi[ID774] - Malaysia[ID775] - Maldives[ID776] - Mali[ID777] - Malta[ID778] - Marshall Islands[ID779] - Mauritania[ID780] - Mauritius[ID781] - Mexico

40

[ID782] - Micronesia[ID783] - Monaco[ID784] - Mongolia[ID785] - Montenegro[ID786] - Morocco[ID787] - Mozambique[ID788] - Myanmar[ID789] - Namibia[ID790] - Nauru[ID791] - Nepal[ID792] - Netherlands[ID793] - New Zealand[ID794] - Nicaragua[ID795] - Niger[ID796] - Nigeria[ID797] - North Korea[ID798] - North Macedonia[ID799] - Norway[ID800] - Oman[ID801] - Pakistan[ID802] - Palau[ID803] - Panama[ID804] - Papua New Guinea[ID805] - Paraguay[ID806] - Peru[ID807] - Philippines[ID808] - Poland[ID809] - Portugal[ID810] - Qatar[ID811] - Republic of Moldova[ID812] - Romania[ID813] - Russian Federation[ID814] - Rwanda[ID815] - Saint Kitts and Nevis[ID816] - Saint Lucia[ID817] - Saint Vincent and the Grenadines[ID818] - Samoa[ID819] - San Marino[ID820] - Sao Tome and Principe[ID821] - Saudi Arabia[ID822] - Senegal[ID823] - Serbia[ID824] - Seychelles[ID825] - Sierra Leone[ID826] - Singapore[ID827] - Slovakia[ID828] - Slovenia

41

[ID829] - Solomon Islands[ID830] - Somalia[ID831] - South Africa[ID832] - South Korea[ID833] - South Sudan[ID834] - Spain[ID835] - Sri Lanka[ID836] - Sudan[ID837] - Suriname[ID838] - Sweden[ID839] - Switzerland[ID840] - Syrian Arab Republic[ID841] - Tajikistan[ID842] - Tanzania[ID843] - Thailand[ID844] - Timor-Leste[ID845] - Togo[ID846] - Tonga[ID847] - Trinidad and Tobago[ID848] - Tunisia[ID849] - Turkey[ID850] - Turkmenistan[ID851] - Tuvalu[ID852] - Uganda[ID853] - Ukraine[ID854] - United Arab Emirates[ID855] - United Kingdom[ID856] - United States of America[ID857] - Uruguay[ID858] - Uzbekistan[ID859] - Vanuatu[ID860] - Venezuela[ID861] - Viet Nam[ID862] - Yemen[ID863] - Zambia[ID864] - Zimbabwe



42

months











43










44






45






46










47

weeks










48











49

days

weeks









*

50



51


1

2

3

4

52

months











* Sex:FemaleMale

53



54


55


56


57




58

months











59










60






61






62










63

weeks










64











65

days

weeks









*

66



67


1

2

3

4

68

months











* Sex:FemaleMale

69



70


71


72


73




74

months











75










76






77






78










79

weeks










80











81

days

weeks









*

82



83


1

2

3

4

84

months











* Sex:FemaleMale

85

Country of residence (EU member states):- Austria- Belgium- Bulgaria- Croatia- Cyprus- Czechia- Denmark- Estonia- Finland- France- Germany- Greece- Hungary- Ireland- Italy- Latvia- Lithuania- Luxembourg- Malta- Netherlands- Poland- Portugal- Romania- Slovak Republic- Slovenia- Spain- Sweden

Country of residence (Non- EU member sate):- Afghanistan- Albania- Algeria- Andorra- Angola- Antigua and Barbuda- Argentina- Armenia- Australia- Austria- Azerbaijan- Bahamas- Bahrain- Bangladesh- Barbados- Belarus

86

- Belgium- Belize- Benin- Bhutan- Bolivia- Bosnia and Herzegovina- Botswana- Brazil- Brunei Darussalam- Bulgaria- Burkina Faso- Burundi- Cabo Verde- Cambodia- Cameroon- Canada- Central African Republic- Chad- Chile- China- Colombia- Comoros- Congo- Costa Rica- Côte D'Ivoire- Croatia- Cuba- Cyprus- Czechia- Democratic Republic of the Congo- Denmark- Djibouti- Dominica- Dominican Republic- Ecuador- Egypt- El Salvador- Equatorial Guinea- Eritrea- Estonia- Eswatini- Ethiopia- Fiji- Finland- France- Gabon- Gambia

87

- Georgia- Germany- Ghana- Greece- Grenada- Guatemala- Guinea- Guinea Bissau- Guyana- Haiti- Honduras- Hungary- Iceland- India- Indonesia- Iran- Iraq- Ireland- Israel- Italy- Jamaica- Japan- Jordan- Kazakhstan- Kenya- Kiribati- Kuwait- Kyrgyzstan- Laos- Latvia- Lebanon- Lesotho- Liberia- Libya- Liechtenstein- Lithuania- Luxembourg- Madagascar- Malawi- Malaysia- Maldives- Mali- Malta- Marshall Islands- Mauritania- Mauritius- Mexico

88

- Micronesia- Monaco- Mongolia- Montenegro- Morocco- Mozambique- Myanmar- Namibia- Nauru- Nepal- Netherlands- New Zealand- Nicaragua- Niger- Nigeria- North Korea- North Macedonia- Norway- Oman- Pakistan- Palau- Panama- Papua New Guinea- Paraguay- Peru- Philippines- Poland- Portugal- Qatar- Republic of Moldova- Romania- Russian Federation- Rwanda- Saint Kitts and Nevis- Saint Lucia- Saint Vincent and the Grenadines- Samoa- San Marino- Sao Tome and Principe- Saudi Arabia- Senegal- Serbia- Seychelles- Sierra Leone- Singapore- Slovakia- Slovenia

89

- Solomon Islands- Somalia- South Africa- South Korea- South Sudan- Spain- Sri Lanka- Sudan- Suriname- Sweden- Switzerland- Syrian Arab Republic- Tajikistan- Tanzania- Thailand- Timor-Leste- Togo- Tonga- Trinidad and Tobago- Tunisia- Turkey- Turkmenistan- Tuvalu- Uganda- Ukraine- United Arab Emirates- United Kingdom- United States of America- Uruguay- Uzbekistan- Vanuatu- Venezuela- Viet Nam- Yemen- Zambia- Zimbabwe



90

months











91










92






93






94










95

weeks










96











97

days

weeks









*

98



99


1

2

3

4

100

months











* Sex:FemaleMale

101



102


103


104


105




106

months











107










108






109






110










111

weeks










112











113

days

weeks









*

114



115


1

2

3

4

116

months











* Sex:FemaleMale

117



118


119


120


121




122

months











123










124






125






126










127

weeks










128











129

days

weeks









*

130



131


1

2

3

4

132

months











* Sex:FemaleMale

133



134


135


136


137




138

months











139










140






141






142










143

weeks










144











145

days

weeks









*

146



147


1

2

3

4

148

months











* Sex:FemaleMale

149



150


151


152


153




154

months











155










156






157






158










159

weeks










160











161

days

weeks









*

162



163


1

2

3

4

164

months











* Sex:FemaleMale

165



166


167


168


169




170

months











171










172






173






174










175

weeks










176











177

days

weeks









*

178



179


1

2

3

4

180

months











* Sex:FemaleMale

181



182


183


184


185




186

months











187










188






189






190










191

weeks










192











193

days

weeks









*

194



195


1

2

3

4

196

months











* Sex:FemaleMale

197



198


199


200


201




202

months











203










204






205






206










207

weeks










208











209

days

weeks









*

210



211


1

2

3

4

212

months











* Sex:FemaleMale

213



214


215


216


217




218

months











219










220






221






222










223

weeks










224











225

days

weeks









*

226



227


1

2

3

4

228

months











* Sex:FemaleMale

229



230


231


232


233




234

months











235










236






237






238










239

weeks










240











241

days

weeks









*

242



243


1

2

3

4

244








SUBMIT

If you have more than fifteen cases to report, please submit a new survey.

245

Documents

EPIDEMIOLOGICAL AND MEDICAL BURDEN OF THE COVID-19